GlassScriptPhysician profile
Regina Ney
NPI 1427248111
$422.53
in general payments reported to CMS, 2019-2025
12 companies · $17.52 in 2025
The $17.52 reported for 2025 was less than what a typical Women'S Health (Nurse Practitioner) provider received nationally (typical 2025 total: $123).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $332 · 2022: $28.81 · 2024: $44.29 · 2025: $17.52.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $61.81.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $61.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $88.12 | 2021 | |
| Evofem Biosciences, INC. | $79.23 | 2021 | |
| Abbvie INC. | $72.13 | 2021 | |
| Cranial Technologies, INC | $46.33 | 2022-2025 | Doc Band |
| Mayne Pharma Commercial LLC | $28.35 | 2021 | |
| Glaxosmithkline, LLC. | $25.45 | 2024 | Bexsero |
| Organon LLC | $18.84 | 2024 | |
| Coopersurgical, INC. | $14.25 | 2021 | |
| Agile Therapeutics, INC. | $13.68 | 2021 | |
| Merck Sharp & Dohme LLC | $12.97 | 2021 | |
| Astellas Pharma US INC | $11.96 | 2021 | |
| Avion Pharmaceuticals | $11.22 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Regina Ney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.